Biohaven

It was great connecting with the nephrology community at the @ERAkidney Congress in Glasgow. Thank you to everyone who stopped by our booth to learn more about our TRAP™ degrader and shared meaningful conversations with our team. See you next year! #ERA26

Our Chief Translational Officer will be speaking at the @GoldmanSachs Annual Global Healthcare Conference, sharing insights on our pipeline developments. #DaysMatter #Innovation #Pipeline

We’re excited to be part of the important conversations happening in metabolic health at @ADA_DiabetesPro. These discussions are critical to advance a deeper understanding of the complexity of obesity, and to drive scientific progress forward. #ADASciSessions #MedEd

Our annual Research & Development Day brought together our leadership team, industry experts and investors to share the latest on Biohaven’s pipeline progress in immunology, epilepsy, obesity and more. View the presentation here: brnw.ch/21x344H #DaysMatter #Investors

Biohaven is heading to the @ERAkidney Congress with a booth highlighting our TRAP™ degrader. Come stop by, say hello to our team and learn more about our work in kidney disease: brnw.ch/21x324Y #ERA26 #DaysMatter #IgAN #KidneyDisease #MedEd

Connecticut innovation was front and center at the Yale Innovation Summit! Our CEO joined healthcare leaders for a panel discussion on building and scaling companies within Connecticut’s growing biotech ecosystem. #YaleInnovationSummit #Connecticut #Biotech #DaysMatter

We look forward to connecting with peers across the ecosystem at the Yale Innovation Summit and advancing conversations that help bring new scientific breakthroughs closer to patients. Join us: brnw.ch/21x2PV6 #YaleInnovationSummit #Biotech #Innovation

Purpose and empathy help drive scientific innovation. Shodeinde Coker, M.D. shares his oncology journey and commitment to advancing new treatments for people facing cancer. Read more: brnw.ch/21x2CMk #DaysMatter #Oncology #ADCs

Biohaven is featured in the news for our differentiated approach to obesity treatment — one focused not just on weight loss, but on improving body composition by targeting fat reduction while building muscle. Read more about our experimental program: brnw.ch/21x2sdG

#Investors: Our Chief Medical Officer and SVP of Finance will participate in a fireside chat at the Bank of America Global Healthcare Conference, sharing insights on our pipeline developments. #DaysMatter #Innovation #Pipeline

In his recent article, Brian McGuire, M.D., shares how his experience in emergency medicine continues to shape his work in drug development and his commitment to helping patients. Read more: brnw.ch/21x20Eg #ThoughtLeadership #DaysMatter #PrecisionMedicine

We loved connecting with clinicians, researchers and advocates at #AAN2026 who share our mission: advancing science to improve patient outcomes. #DaysMatter #Neuroscience #Epilepsy #ParkinsonsDisease

Stop by our booth at #AAN2026 to meet our team, learn about our pipeline and see how we’re advancing science to improve patient outcomes. #DaysMatter #Neuroscience #Epilepsy #ParkinsonsDisease #Degraders

Congratulations to our CEO on being named the 2026 Howard Zonana Prize recipient by the @YaleMed Law and Psychiatry Division! This honors an alumnus of Yale’s forensic psychiatry fellowship who has made outstanding contributions to psychiatry as a clinician, educator and scholar.

Our CMO, Oncology will join leaders at the Chief Medical Officer Summit 360 to discuss how AI can help optimize clinical trials and accelerate insights across drug development. Meet us there: brnw.ch/21x1rRG #CMO360 #ClinicalDevelopment #AI #DrugDevelopment

We’re sharing preclinical data on our MoDE™ degrader in pemphigus vulgaris, a rare autoimmune skin disease, at the upcoming @AADmember Annual Meeting. Register here: bit.ly/3ZJ5X92 #AAD2026 #MedEd #DaysMatter

The @MichaelJFoxOrg Foundation is hosting its Parkinson’s IQ + You event in Nevada this weekend and our Chief Medical Officer will be speaking on the panel, “Exploring the Latest in Parkinson’s Research”, to share his perspective on the evolving landscape: bit.ly/4r9oKW8

Our CEO will join industry leaders at the R&D Leadership Summit for a discussion on how the industry can drive innovation and deliver transformative medicines balancing large-scale therapeutic opportunities with the growing potential of precision science: brnw.ch/21x0w1L

Our CEO will be participating in the @Yale Entrepreneurial Society Dinner this week, where he will share his journey through academic medicine, biotech entrepreneurship and the founding of Biohaven. #Yale #Entrepreneurship

Our Chief Translational Officer is presenting at the TD Cowen Health Care Conference sharing an update on our pipeline and the platform technologies driving it including our degrader, ion channel, oncology and myostatin programs. #DaysMatter #Investors #TDcowenHealthcare